Botanix制药公司获得4000万澳元两轮增发坚定承诺,新股发行价每股0.06澳元

美股速递
Feb 17

Botanix Pharmaceuticals Ltd(澳交所代码:BOT)宣布已成功获得总额4000万澳元的两轮增发坚定认购承诺。此次增发的新股定价为每股0.06澳元,标志着市场对该公司发展前景的强劲信心。

这项融资计划将分两个阶段实施,旨在为公司的研发项目和运营扩张提供资金支持。每股0.06澳元的发行价反映了投资者对Botanix制药业务战略和增长潜力的认可。此次增发的顺利完成,预计将显著增强公司的资金实力,为其在制药领域的持续创新和市场拓展奠定坚实基础。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10